By Months: Irja Lutsar
Total Months: 9
Fully Profiled: 9
11.2025
2 Speeches
Not enough data
10.2025
15 Speeches
Economic perspectives focus on the allocation of national expenditures, strongly supporting targeted funding for research and development (R&D). The presentation of budgetary data suggests an interest in fiscal transparency and the setting of government priorities.
09.2025
7 Speeches
Not enough data
06.2025
10 Speeches
Economic viewpoints emphasize fiscal responsibility and cost-saving, supporting the saving of 12 million euros on a vacant prison building. He views reforms as a means to help direct money toward sectors suffering from chronic underfunding, such as Estonian healthcare.
05.2025
1 Speeches
There is not enough data.
04.2025
13 Speeches
Economic views favor regulation, supporting the regulation of industry (tobacco producers) and the harmonization of EU rules for the sake of public health. Furthermore, there is an emphasis on the need to boost national investments in medical science and fundamental research to guarantee improved treatment options in the future.
03.2025
5 Speeches
It strongly supports knowledge-based economic growth, emphasizing the need to invest in science and create government programs to attract top scientists to Estonia. It views the introduction of scientists as an opportunity to develop Estonian science without changing doctoral studies.
02.2025
2 Speeches
Economic viewpoints stress the necessity of investing in human capital, offering researchers greater stability and reducing their reliance on grants. Furthermore, support is given to improving the efficiency of public sector data management by avoiding duplication and consolidating the data into a unified infrastructure.
01.2025
11 Speeches
The speaker advocates for state funding for major healthcare projects, stressing that public health is a collective concern and the investment of public funds shouldn't be frowned upon. They are critical of the profit-driven competition between hospitals, preferring a national healthcare system that must guarantee the best and most affordable care for everyone. They also point out that during the pandemic, countries with robust national medical systems fared better than those where private medicine dominated.